Compare AngloGold Ashanti Limited (AU) vs BioNTech SE - ADR (BNTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AngloGold Ashanti Limited vs BioNTech SE - ADR — how do they compare? AngloGold Ashanti Limited trades at $100.99 (market cap $49.28B), while BioNTech SE - ADR trades at $92.8 (market cap $23.31B). The key difference: AngloGold Ashanti Limited is far larger — about 2.1× BioNTech SE - ADR's market cap, and AngloGold Ashanti Limited pays a 4.64% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| AU | BNTX | |
|---|---|---|
Market Cap | $49.28B | $23.31B |
Sector | Basic Materials | Health |
52-Week High | $128.26 | $119.34 |
52-Week Low | $52.15 | $83.89 |
Enterprise Value | $48.29B | $6.60B |
Dividend Yield | 4.64% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AngloGold Ashanti Limited
Anglogold Ashanti Ltd is one of the largest gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from Africa which includes Ghana, Guinea, Mali, the Democratic Republic of the Congo, and Tanzania.
Read more on AU →About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →
